ILT-5 Inhibitors
ILT-5 inhibitors refer to a class of chemical compounds designed to target and modulate the activity of ILT-5, which stands for Immunoglobulin-Like Transcript 5. ILT-5 is a member of the immunoglobulin-like transcript (ILT) family, which consists of cell surface receptors with diverse functions in immune regulation and immune cell interactions. While the exact function of ILT-5 is still being elucidated, it is believed to play a role in immune responses and immune tolerance. These receptors are typically found on the surface of immune cells, including antigen-presenting cells and T cells. Inhibitors of ILT-5 are developed to interfere with its activity, potentially affecting immune cell interactions, signaling pathways, and immune responses regulated by this receptor.
The mechanisms by which ILT-5 inhibitors function can vary based on their chemical structures and binding properties. Some inhibitors may directly interact with ILT-5, preventing its engagement with ligands or other molecules involved in immune cell interactions. Others may modulate the conformation or stability of ILT-5, affecting its ability to transmit intracellular signals or regulate immune responses. By inhibiting ILT-5, these compounds have the potential to influence immune cell activation, immune tolerance, or other processes associated with this receptor, which may have implications for immune regulation and immune-related diseases. Ongoing research in this field aims to elucidate the precise mechanisms and downstream effects of ILT-5 inhibition, contributing to our understanding of its role in immunology and immune cell interactions.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
By inhibiting DNA methyltransferase, it can change the methylation status of genes and possibly reduce the expression of ILT-5 due to altered gene regulation. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
A metabolite of vitamin A that regulates gene expression through nuclear receptors, potentially decreasing ILT-5 transcription in myeloid cells. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $39.00 $59.00 $104.00 $206.00 | 8 | |
It binds to Hsp90 and affects its function, which can lead to the destabilization of client proteins and might indirectly reduce ILT-5 expression. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Known to modulate multiple signaling pathways and could alter the transcriptional regulation of immune-related genes, including ILT-5. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
It interacts with multiple molecular targets within cells, potentially affecting transcription factors that regulate genes like ILT-5. | ||||||
Cobalt(II) chloride | 7646-79-9 | sc-252623 sc-252623A | 5 g 100 g | $64.00 $176.00 | 7 | |
Hypoxic mimic that modulates various hypoxia-inducible factors and genes, which might include downregulation of ILT-5. | ||||||
Oxaliplatin | 61825-94-3 | sc-202270 sc-202270A | 5 mg 25 mg | $112.00 $394.00 | 8 | |
As a platinum-based compound, it forms DNA adducts that can disrupt transcriptional processes and potentially downregulate ILT-5. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
It can modulate the activity of nuclear factor-κB (NF-κB) and other transcription factors that regulate immune gene expression including ILT-5. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
A MEK inhibitor that could interfere with the MAPK/ERK signaling pathway, potentially impacting ILT-5 expression. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
Known to inhibit NF-κB activation, which can lead to changes in the expression of various immune-related genes, possibly including ILT-5. | ||||||